← Evidence map

ArticlePloS one2015

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

Young-Ho Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25769025